HudsonAlpha Innovation Prize Awarded To UAB Professor For T Cell Studies
Main Category: Immune System / VaccinesArticle Date: 11 May 2009 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Dr. Casey Weaver, University of Alabama at Birmingham professor of pathology, has been awarded the 2009 HudsonAlpha Prize for Outstanding Innovation in Life Sciences. The prize, which includes a $20,000 cash award, salutes Weaver's achievements in advancing understanding of immune protection and immune disease through T cell research.
According to Weaver, our bodies use T cells to protect against infections and cancer, but when T cells overreact and turn on the body, we see immune-mediated diseases such as rheumatoid arthritis, inflammatory bowel disease, lupus and multiple sclerosis. "Our studies have contributed to the identification of a new class of T cells, called Th17 cells, which are now recognized as important participants in a growing number of autoimmune diseases," said Weaver.
"By understanding how this class of T cells develops and functions in normal and abnormal immunity, we hope to identify new approaches to curb these cell's destructive potential as a means to treat patients who suffer from certain types of autoimmune disease and perhaps harness this potential to eradicate certain types of infections and malignancies," he added.
The prize, in addition to recognizing exceptional talent and research of superior merit, aims to raise awareness of Alabama's growing life sciences community. Presidents of Alabama's six public research universities could nominate up to two teams or individual candidates from their respective institutions.
Dr. Richard Myers, HudsonAlpha Institute for Biotechnology president and director, presented the award. Myers acknowledged the pool of nominees reflected the high quality of scientific investigation that is ongoing at Alabama's research universities.
The HudsonAlpha prize committee received its recommendations from a distinguished and impartial group of scientists who reside outside the state and who have no connections to participating universities.
Funding for the annual HudsonAlpha Prize for Outstanding Innovation in Life Sciences is provided through a grant by the Alpha Foundation.
Source:
Holly Ralston McClain
HudsonAlpha Institute for Biotechnology
Visit our immune system / vaccines section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/149472.php>
APA
http://www.medicalnewstoday.com/releases/149472.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



